[86] described that RG7834, a novel oral HBV gene expression inhibitor, could decrease the levels of viral proteins and reduce viremia. RG7834 is a small-molecule compound belonging for the dihydroquinolizinones chemical class comparable to RNAi but as a result of a unique system. Unlock enhanced characteristics & extensive drug insights, https://dinahu245jgf3.blogoxo.com/profile